HSK39004 Suspension for Inhalation

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSK39004 Suspension for Inhalation, covering 2025-04-02 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation [Phase 1]

See pricing